The Impact of Social Phone Calls on Adults Who Have Had a Stroke

January 4, 2024 updated by: Jennifer Beauchamp, The University of Texas Health Science Center, Houston
The purpose of this study is to see the impact of social visits, through weekly phone calls, on quality of life and health outcomes of depression, anxiety, loneliness, and self-rated health for adults who have experienced an ischemic or hemorrhagic stroke and to determine the benefit of these conversations on the student volunteer's perspective of adults who have survived a stroke

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

14

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Houston, Texas, United States, 77030
        • The University of Texas Health Science Center at Houston

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • have a UCLA short form score of 4 or higher
  • can read, write, and speak English
  • have had an ischemic or hemorrhagic stroke is the past year
  • have a telephone and are available for weekly phone calls
  • provide informed consent agreeing to be contacted by the volunteers

Exclusion Criteria:

  • reside outside of the home
  • have Electronic Health Record documentation of Aphasia
  • Montreal Cognitive Assessment score of <9

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Treatment group
Following the collection of baseline data, the study participant will be randomly assigned to a student volunteer to begin the social phone calls. The first phone call will be scheduled to occur within one week of the consent and baseline assessments. A minimum of one social phone call will occur each week for 6weeks. Each phone call is expected to last around 1 hour with flexibility to be shorter or longer. The calls will be unstructured and designed simply to engage in conversation with the participant. The length of the phone calls, days and times will be recorded by the volunteer along with a short journal entry describing the conversation topics and any information that stood out to the volunteer. If the stroke survivor and student volunteer wish to speak more than the designated one call a week, that will be allowed if both parties agree. The same student volunteer will conduct all six sessions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Feasibility as assessed by the number of participants who enrolled in the study
Time Frame: post intervention (6 weeks from start of intervention)
post intervention (6 weeks from start of intervention)
Feasibility as assessed by the number of participants who completed all 6 phone calls
Time Frame: post intervention (6 weeks from start of intervention)
post intervention (6 weeks from start of intervention)
Feasibility as assessed by the number of participants who completed all the assessments
Time Frame: post intervention (6 weeks from start of intervention)
post intervention (6 weeks from start of intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in loneliness as assessed by the University of California, Los Angeles (UCLA) Loneliness Scale
Time Frame: Baseline, post intervention (6 weeks from start of intervention)
This is a 20 item questionnaire, each one is scored form 1(never) to 4(always). Scores for questions 1,5,6,9,10,15,16,19 and 20 are reversed(i.e. 1=4,2=3,3=2,4=1)and the scores for each item is then summed together, higher number indicating more loneliness
Baseline, post intervention (6 weeks from start of intervention)
Change in depression as assessed by the Center for Epidemiologic Studies Depression Scale (CES-D)
Time Frame: Baseline, post intervention (6 weeks from start of intervention)
This is a 20 item questionnaire, each item is scored from 0(rarely or none of the time)-3 (most or all of the time) with a possible range of scores from 0-60 a higher score indicating more depression
Baseline, post intervention (6 weeks from start of intervention)
Change in anxiety as assessed by the Generalized Anxiety Disorder 7 Scale (GAD 7)
Time Frame: Baseline, post intervention (6 weeks from start of intervention)
This is a 7 item questionnaire, each is scored from 0(not at all) to 3(nearly every day) a higher number indicating more anxiety
Baseline, post intervention (6 weeks from start of intervention)
Change in social support as assessed by the Duke Social Support Index (DSSI) Scale
Time Frame: Baseline, post intervention (6 weeks from start of intervention)
This is a 10 item questionnaire and each is scored from 1-3,with a maximum score of 30 and higher score indicating higher levels of support
Baseline, post intervention (6 weeks from start of intervention)
Change in resilience as assessed by the brief resilience scale
Time Frame: Baseline, post intervention (6 weeks from start of intervention)
This is a 6 item questionnaire and each is measured from 1(strongly disagree)-5(strongly agree) for maximum score of 30 a higher score indicating greater resilience to stressful events
Baseline, post intervention (6 weeks from start of intervention)
Change in pain as assessed by the Brief Pain Inventory Short Form
Time Frame: Baseline, post intervention (6 weeks from start of intervention)

This questionnaire has 2 subscales :

The first subscale is the pain severity subscale which consists of 4 questions and each are scored from 0(no pain)-10(severe pain), a higher number indicating more pain

The second subscale is the pain interference score and it contains 7 items and each is scored from 0(does not interfere)-10(completely interferes) a higher number indicating worse outcome.

Baseline, post intervention (6 weeks from start of intervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jennifer Beauchamp, PhD, RN, The University of Texas Health Science Center, Houston

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 23, 2023

Primary Completion (Actual)

June 12, 2023

Study Completion (Actual)

June 12, 2023

Study Registration Dates

First Submitted

March 15, 2023

First Submitted That Met QC Criteria

March 30, 2023

First Posted (Actual)

March 31, 2023

Study Record Updates

Last Update Posted (Actual)

January 5, 2024

Last Update Submitted That Met QC Criteria

January 4, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Social Phone Calls

Subscribe